ThomasHBurwinkelMD

Obstetrics & Gynecology • Cincinnati, OH

Reproductive Endocrinology & Infertility

Institute for Reproductive Health

Join to view full profile

Dr. Burwinkel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Burwinkel's full profile

Already have an account?

Office
3805 Edwards Road
Suite 450
Cincinnati, OH 45209
Phone+1 513-924-5550

Fax+1 513-924-5551
Is this information wrong?

Summary

Dr. Thomas Burwinkel is an obstetrician/gynecologist in Cincinnati, OH and is affiliated with multiple hospitals in the area, including Miami Valley Hospital and Christ Hospital. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 31 years. He specializes in reproductive endocrinology & infertility and is experienced in reproductive and sexual endocrinology and reproductive genetics.

Education & Training

TriHealth (Bethesda Hospital)Residency, Obstetrics and Gynecology, 1986 - 1990
University of Cincinnati College of MedicineClass of 1986

Certifications & Licensure

KY State Medical License 1987 - 2025
OH State Medical License 1987 - 2025
TN State Medical License 1990 - 1992
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Publications & Presentations

PubMed

2 citations
Platelet activating factor treatment of spermatozoa enhances rabbit oocyte fertilization following subzonal sperm insertion
Brijinder S. Minhas, Hak Nam Kim, Y.P. Zhu, Barry A. Ripps, Thomas H. Burwinkel> ;Journal of Assisted Reproduction and Genetics. 1994 Jul 1
1 citations
Embryo survival after pronuclear microinjection and trophectoderm biopsy.
Thomas H. Burwinkel, Hak-Nam Kim, John E. Buster, Brijinder S. Minhas, Sandra Ann Carson> ;American Journal of Obstetrics and Gynecology. 1994 Apr 1
13 citations
Basal follicle stimulating hormone (FSH) predicts response to controlled ovarian hyperstimulation (COH)-intrauterine insemination (IUI) therapy.
Thomas H. Burwinkel, John E. Buster, Janet L. Scoggan, Sandra A. Carson> ;Journal of Assisted Reproduction and Genetics. 1994 Jan 1
11 citations
Platelet-activating factor production from in vitro and in vivo fertilized murine embryos is similar
Barry A. Ripps, Y.P. Zhu, Thomas H. Burwinkel, Hak-Nam Kim, John E. Buster, Brijinder S. Minhas> ;American Journal of Reproductive Immunology. 1993 Sep 10
24 citations
Embryonic platelet activating factor production in the rabbit increases during the preimplantation phase.
Brijinder S. Minhas, Y.P. Zhu, Hak-Nam Kim, Thomas H. Burwinkel, Barry A. Ripps, John E. Buster> ;Journal of Assisted Reproduction and Genetics. 1993 Jul 1
Platelet activating factor and conception.
Minhas, B. S., Ripps, B. A., Zhu, Y. P., Kim, H. N., Burwinkel, T. H., Gleicher, N.> ;Am J Reprod Immunol. 1996 Mar
Predicting pregnancy survival from a single first trimester vaginal ultrasonogram.
Burwinkel, T. H., Emerson, D. S., Buster, J. E., Felker, R. E., Altieri, L. A., Carson, S. A.> ;J Ultrasound Med. 1993 Nov
Join now to see all